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TransplantatABSTRACT
Objective. To access the incidence of infectious problems after liver transplantation (LT).
Design. A retrospective, single-center study.
Materials and Methods. Patients undergoing LT from January 2008 to December 2011
were considered. Exclusion criterion was death occurring in the ﬁrst 48 hours after LT. We
determined the site of infection and the bacterial isolates and collected and compared
recipient’s variables, graft variables, surgical data, post-LT clinical data.
Results. Of the 492 patients who underwent LT and the 463 considered for this study,
190 (Group 1, 41%) developed at least 1 infection, with 298 infections detected. Of these,
189 microorganisms were isolated, 81 (51%) gram-positive bacteria (most frequently
Staphylococcus spp). Biliary infections were more frequent (mean time of 160.4  167.7
days after LT); from 3 months after LT, gram-negative bacteria were observed (57%).
Patients with infections after LT presented lower aminotransferase levels, but higher
requirements in blood transfusions, intraoperative vasopressors, hemodialysis, and
hospital stay. Operative and cold ischemia times were similar.
Conclusion. We found a 41% incidence of all infections in a 2-year follow-up after LT.
Gram-positive bacteria were more frequent isolated; however, negative bacteria were
commonly isolated later. Clinical data after LT were more relevant for the development
of infections. Donors’ variables should be considered in future analyses.*Address correspondence to Paulo Marcelino, Hospital Curry
Cabral, Intensive Care Unit, Rua da Beniﬁciência, 8; 1069-166
Lisboa, Portugal. E-mail: par.marcelino@gmail.comINFECTIOUS diseases are a common problem after solidorgan transplantation, especially after liver transplant
(LT) [1]. Infections cause signiﬁcant morbidity and mor-
tality, which affect graft survival [2]. The described rate is
variable, with most of them being bacterial infections [3,4].
Many factors are taken into account. These include donor
variables (active infection, prolonged intensive care unit
[ICU] stay, and acute kidney injury); graft variables (its
quality and presence of steatosis); recipient data variables
(such as poor nutritional status, clinical characteristics
[model for end stage liver disease, MELD, and Child-
Turcotte-Pugh fCTPg scores]) [5e8]; and intraoperative
data (volume of transfused blood, and ischemia-reperfusion
injury [IRI]) [9]. All these patients start immunosuppression
early, so more infectious complications can develop after LT.
In recent years, many improvements have taken place
regarding organ allocation (especially after the introductionlsevier Inc. All rights reserved.
enue South, New York, NY 10010-1710
ion Proceedings, 47, 1019e1024 (2015)of the MELD score) [10], surgical technique, antimicrobial
and antifungal prophylaxis, and immunosuppression [11].
Nonetheless, the frequency of infectious events after LT did
not decrease signiﬁcantly [12]. Regional differences may
exist; thus, the infectious events can vary from center to
center as well as between countries. Data from various
centers, then, help to obtain a clearer picture of this
particular problem in these patients.
Our liver transplant center is a leading center in the
country. In this study, the rate of all infections after LT is
described, in a 2-year follow-up.0041-1345/15
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All patients who underwent LT from January 2008 to December
2011 were considered for enrollment. As well as patients who died
intraoperatively, patients who died in the ﬁrst 48 hours after LT
were excluded.
Patients who undergo LT in our center receive antimicrobial
prophylaxis with ceftazidime 1 g, and amoxicillin and clavulanic acid
1.2 g, both intravenously and 3 times a day; oral nystatin every 6
hours; and, for females, vaginal clotrimazole once a day. In selected
patients (deﬁned by the presence of at least 1 of the following
conditions: urgent LT due to acute liver failure or acute-on-chronic
liver failure; serum creatinine >2 mg/dL prior to LT or hemodial-
ysis preceding LT; early acute kidney injury [AKI] after LT with
need for renal replacement technique; retransplantation; early post-
LT need for surgical reintervention [mainly due to vascular com-
plications and bleeding]; or more than 40 U of transfused cellular
blood components), prophylaxis with liposomal amphotericin B
(L-AmB) was given as an intravenous administration of 100 mg
daily for 14 days. The usual immunosuppressive therapy used in our
center consists of prednisolone, in a dose of 3 mg/kg i.v. in the ﬁrst
days, decreasing 20e30 mg/day until reaching the maintenance dose
of 20 mg/day; mycophenolate mophetil, 500 mg b.i.d. (according to
platelet and white blood cell count); calcineurin inhibitors CNI
(cyclosporine A, 8 mg/kg/day or tacrolimus, 0.1 mg/kg/day), to
attain a target serum level of 350e400 ng/mL for CYA and 8e12 ng/
mL for TCR. Patients with renal impairment previous to LT
received basiliximab 4 mg in the ﬁrst day and 4 mg in the fourth
postoperative day; in these patients, CNI is introduced after 7 days.
The hepatologist prescribes all the immunosuppressors.
The data collected were recipient’s age; gender; operative time;
cold ischemia time; pre-LTMELD and CTP scores; development of
acute kidney injury (AKI) after LT (using the AKI classiﬁcation);
hemodynamic instability during surgery (deﬁned as the continuous
infusion of vasopressor for more than 5 minutes); maximum alanine
aminotransferase (ALT) and aspartate aminotransferase (AST)
levels after LT; number of RBC units transfused during surgery;
ICU and hospital stay; and type of LT (deceased-donor LT or
sequential LT). All infections were considered during the study
period, determined by the presence of a documented site of infec-
tion and/or isolated infectious agent.
In these cases, several samples of body ﬂuids were collected for
microbiological analysis on suspicion of infection. For study
purposes, they were divided as follows: biliary tract infections; res-
piratory infections; urinary tract infections; bloodstream infections
(BSI); surgical wound infections; undetermined infections (febrile
patients, in whom antibiotics were used, but without a proven site of
infection or microbial isolates); opportunistic infections (caused by
typically opportunistic agents, such as cytomegalovirus or Pneumo-
cystis jiroveci); and fungal infections. These infections also were
analyzed, to determine the mean days of detection after LT, the most
common pathogens found (except for undetermined infections), and
the antibiotics used, by order of frequency. A separate analysis was
performed for patients presenting biliary tract infections and respi-
ratory tract infections.
Deceased-donor liver grafts were harvested from brain-dead,
heart-beating donors (the majority from other Portuguese in-
stitutions), preserved in Celsior solution and implanted in the
recipient using the piggyback technique. In domino liver trans-
plantation (DLT), the native hepatectomy in familial amyloidotic
polyneuropathy (FAP) patients and the implantation of the
deceased-donor graft were also done in the standard piggyback
fashion, with retrohepatic vena cava preservation and withoutvenovenous bypass. FAP livers also were ﬂushed with and main-
tained in the Celsior solution. As FAP liver grafts were harvested
without the vena cava, the hepatic venous outﬂow of the domino
grafts was reconstructed on the back table, using a vein graft from
the deceased donor as previously described [13]. Following the
reconstruction of the hepatic venous outﬂow, the portal vein, he-
patic artery, and bile duct were anastomosed.
All patients undergoing LT must sign an informed consent. The
present protocol for data collection was reviewed and approved by
the institution’s ethics board.
Continuous variables are expressed as an average and standard
deviation. Categorical variables are presented as categories with
percentages. For comparative analysis, parametric (Student t test,
for numeric variables, after conﬁrmation of the normal distribution
of data by the Kolmogorov-Smirnov test) and nonparametric tests
(c2 test or Fisher exact test, for categorical variables) were used. To
establish dependence between variables, logistic regression analysis
was performed (backward-LR), using variables that were signiﬁcant
on univariate analysis, and a goodness-of-ﬁt test (Hosmer-Lemeshow)
was used to assess the ﬁt of the logistic regression model. A
P value <.05 was considered statistically signiﬁcant. Statistical
analysis was performed using SPSS 19.0 (Statistical Package for
Social Sciences Inc., Chicago, Ill., United States).RESULTS
In the study period, 492 patients underwent LT. Of these, 29
died either during surgery or in the ﬁrst 48 hours after LT
and were excluded. For study purposes, a total of 463 pa-
tients were considered. From these, 190 (41%) developed
at least 1 infection, and 63 developed a second or more
infection during the follow-up period. Overall, 298 in-
fections and 189 identiﬁcations of infectious agents were
registered.
In Table 1 the comparative characteristics of the patients
are shown, divided by those who did not present any in-
fectious disease and those who did. We observed that in
patients who developed infections the aminotransferases
level was lower; nonetheless, the overall hospital stay was
higher. Group 1 patients showed a higher mean AKI level,
not reaching statistical signiﬁcance, but renal replacement
techniques were more often used. Deaths were higher in
Group 1 (29 vs 18, P ¼ .001), although the overall survival
was not signiﬁcantly different, by the end of the study
period. In Group 1, 21 deaths were attributable to infectious
causes, all due to sepsis and multiorgan failure. Of these, 14
presented undetermined site of infection and/or no bacterial
isolates, 1 presented biliary infection, 1 intra-abdominal
infection, 2 BSI, and 1 surgical wound infection. Two
other patients presented irreversible respiratory failure due
to P.s jiroveci infection. There were similar graft losses (3 in
Group 1, 4 in Group 2) and retransplantation (2 in each
group). The mean time from LT to death was 190  377
days in group 1 (10 occurred in the ﬁrst 3 months), and
164  209 in Group 2 (7 occurred in the ﬁrst 3 months).
In Table 2, the incidence of infections is shown, divided
by location, time after LT, and isolated agents. Overall, 189
microorganisms were isolated, separated by the Gram
strain, and major species of microorganisms. We note that
Table 1. Patients Characteristics, Separated by the Presence of Infectious Diseases
Parameter Patients With Infection (n ¼ 190) Patients Without Infection (n ¼ 273) P
Age (years, mean and SD) 47.3  12.6 46.5  12.6
Main pathologies (n and %)
Acute liver failure 6 (3.4%) 16 (5.5%)
Compensated cirrhosis 126 (72.5%) 215 (74.5%)
FAP 42 (24.1%) 58 (20%)
Deceased-donor recipients (n and %) 110 (63.2%) 161 (55.7%)
MELD score (mean and SD) 14.4  4.2 13.4  4
CTP score (mean and SD) 6.6  2.3 6.5  2.2
Operative time (minutes, mean and SD) 325  63 321  60
Cold ischemia time (minutes, mean and SD) 387  68 371  63
Maximum ALT (IU, mean and SD) 1287  1150 1652  1838 .033
Maximum AST (IU, mean and SD) 1948  1973 2593  3572 .025
Intraoperative hemodynamic instability (n and %) 72 (41.3%) 75 (25.9%) .001
RBC (units, mean and SD) 4.9  4.5 3.8  4.2
Mean AKI score (mean and SD) 1.1  1 0.84  1.1
Hemodialysis (n and %) 7 (4%) 8 (2.7%) .001
ICU stay (days, mean and SD) 5.25  4.1 5.9  7.2
Hospital stay (days, mean and SD) 23.7  12. 19.3  9.4 .006
Deceased (at 2 years) 29 (15.2%) 18 (6.5%) .001
Mean survival after LT (at 31st December 2012;
days, mean and SD)
913  584 1023  426 ns
Abbreviations: SD, standard deviation; FAP, familial amyloidotic polyneuropathy; MELD, Model for End-stage Liver Disease; CTP, Child-Turcotte-Pugh; ALT, alanine
aminotransferase; AST, aspartate aminotransferase; IU, international units; RBC, red blood cell; AKI, acute kidney injury; ICU, intensive care unit.
INFECTIONS AFTER LIVING TRANSPLANTATION 1021Staphylococcus aureus spp were more frequently and earlier
isolated. As shown in Table 3, of the bacterial agents, gram-
positive agents were more frequent in the ﬁrst 90 days after
LT, whereas gram-negative agents were more frequent
thereafter.
Regarding patients with biliary tract infection, it was not
found to be a signiﬁcant difference, apart from a longer
hospital stay (28.3  13 vs 20.5  10.5; P ¼ .011) and lower
AST level (1740 1534 vs 2401  3181; P¼ .05). The group
of patients with respiratory tract infection were older
(51.4  11.1 vs 46.5  12.6; P ¼ .026) and stayed longer in
the hospital (28.6  9.2 vs 20.9  11; P ¼ .023).
By logistic regression analysis, no individual parameter
was found to be independently related to the considered
dependent variables: occurrence of infection, occurrence of
biliary tract infection, or occurrence of respiratory tract
infection.DISCUSSION
This study, performed in a single LT center, revealed a 41%
prevalence of infection in a 2-year follow-up. The most
frequent were biliary tract infections, with a mean time of
occurrence of 160.4  167.7 days after transplant. The most
frequently isolated were gram-positive bacteria, although
gram-negative bacteria prevailed in urinary tract infections
and were more frequently isolated after the ﬁrst 90 days
after LT. These data are in general accordance with that
described in the literature, although other authors describe
a higher incidence of infections. Piselli et al. [14] described a
rate of 56.3% and Souza et al. [15] reported a rate of 55.3%,whereas Vera et al. [16] reported an incidence of 55.3%. In
another period, after 1 year post LT, Aberjet et al. [17]
described an incidence of 31% of infections. Note that
these studies were conducted in different countries and
continents and represented different periods after LT. So,
local conditions are critical to the pattern of infectious
diseases in this group of patients, and this knowledge is
valuable in treating them at a particular LT center. Gram-
positive bacteria are also described as the main bacterial
isolates fond in these patients, particularly Staphylococcus
spp. Also, some authors noticed a shift toward higher rate of
gram-negative isolates. However, we found that these were
more frequent later after LT.
A relatively high number of patients presented infectious
problems without an identiﬁable point of infection or
bacterial isolate. By the time of occurrence, they were very
close to BSI, so we may surmise that most of these cases are
BSI, although not detected by microbiological analyses
[18,19].
Aminotransferase levels after LT depend on graft quality
(one of the donor’s related variables), harvesting, and cold
ischemia time, as well as on intraoperative data, such as
operative time, blood transfusion requirement (hemor-
rhage), and need for vasopressors (the hallmark of hemo-
dynamic instability). These were described by Howard et al.
as preservation injury [20]. We observed that aminotrans-
ferase were higher in the group that did not develop any
infection, and only the need for vasopressors was higher in
Group 1. This was true even for biliary tract infection. We
analyzed these cases separately, assuming that there could
be a link between preservation injuries, ischemia-associated







After LT TotalInfectious Agent
Biliary tract 28 26 54
Gram negative 15 15 30
Acinetobacter baumanii 4 3 7
Escherichia coli 2 3 5
Pseudomonas aeruginosa 1 3 4
Klebsiella pneumoniae 2 1 3
Enterobacter cloacae 2 1 3
Other 3 4 7
Gram positive 15 11 26
Enterococcus faecium 9 6 15
Methicillin-resistant Staph. aureus 3 0 3
Enterococcus faecalis 2 1 3
Methicillin-sensitive Staph. aureus 0 3 3
Other 1 1 2
Intra-abdominal 6 2 8
Gram negative 3 1 4
Pseudomonas aeruginosa 2 0 2
Enterobacter cloacae 1 0 1
Citrobacter freudii 0 1 1
Gram positive 3 1 4
Enterococcus faecium 2 1 3
Clostridium difﬁcile 1 0 1
Operative wound 13 0 13
Gram negative 2 0 2
Serratia marcencens 1 0 1
Proteus mirabilis 1 0 1
Gram positive 11 0 11
Methicillin-resistant Staph. aureus 8 0 8
Methicillin-sensitive Staph. aureus 3 0 3
Urinary tract 21 18 39
Gram negative 15 17 32
Escherichia coli 9 12 21
Klebsiella pneumoniae 5 4 9
Pseudomonas aeruginosa 1 0 1
Enterobacter cloacae 0 1 1
Gram positive 6 1 7
Enterococcus faecium 4 0 4
Enterococcus faecalis 2 1 3
Respiratory 8 9 17
H1N1 0 1 1
Gram negative 3 3 6
Acinetobacter baumanii 1 1 2
Klebsiella pneumoniae 1 0 1
Streptococcus pyogenes 1 0 1
Haemophilus inﬂuenzae 0 1 1
Pseudomonas aeruginosa 0 1 1
Gram positive 5 5 10
Methicillin-resistant Staph. aureus 4 4 8
Vancomycin-resistant enterococci 1 0 1
Methicillin-sensitive Staph. aureus 0 1 1
Bloodstream 17 4 21
Gram negative 3 1 4
Acinetobacter baumanii 2 0 2
Pseudomonas aeruginosa 1 0 1







After LT TotalInfectious Agent
Gram positive 14 3 17
Methicillin-resistant Staph. aureus 9 3 12
Enterococcus faecalis 2 0 2
Staphylococcus epidermidis 2 0 2
Enterococcus faecium 1 0 1
Opportunistic 4 10 14
CMV 4 3 7
Pneumocistis jirovecii 0 4 4
Varicella 0 3 3
Other 0 7 17
Gram positive 0 7 17
Methicillin-resistant Staph. aureus 0 4 4
Methicillin-sensitive Staph. aureus 0 3 3
Fungal Infection 5 0 5
Candida 5 0 5
TOTAL 103 76 189
1022 ANTUNES, TEIXEIRA, FORTUNA ET ALbiliary disease after LT, and infection in this location. Even
baseline patients’ characteristics do not explain this fact,
since patients with acute liver failure and FAP patients were
similar in each group. One can conclude that graft-related
factors and probably donor-related factors can contribute
to the development of infections after LT. We could not
ﬁnd any comparative data in the literature.
Recipient characteristics also did not inﬂuence the
occurrence of infections. The clinical data (MELD and
CTP score) and all baseline characteristics were similar in
both groups. Some data in the literature describe higher
incidence of infections in patients with higher MELD
scores; perhaps in these patients, often with acute or acute-
on-chronic disease, bacteriological surveillance is higher and
they could receive more antimicrobial prophylaxis or more
aggressive therapy; frequently they undergo LT with
ongoing antibiotic treatment. There are conﬂicting reports
on the altered infection patterns after introduction of
MELD score. This study was not designed to answer this
question, but the main issue is that patient characteristics
did not interfere with the occurrence of infections.
Regarding surgical data, the only variables signiﬁcantly
different in the group that developed infection were the
need for vasopressor support, a surrogate for intraoperative
hemodynamic instability, and RBC requirements. None-





n % n % n %
Gram positive 53 51% 28 37% 81 43%
Gram negative 41 40% 37 49% 78 41%
INFECTIONS AFTER LIVING TRANSPLANTATION 1023course early after LT and are not necessarily related to graft
quality or preclinical conditions. We could not ﬁnd a similar
description in the literature. Nonetheless, this hemodynamic
instability can particularly affect the post-LT clinical course,
including graft function. A higher RBC requirement also is
described in the literature as a risk factor for infections
after LT.
Regarding the clinical course after LT, patients with
infections had a similar incidence of AKI, although they
required renal replacement techniques more often. The
need for dialysis is a known risk factor for the development
of infections after LT, both bacterial and fungal. Although
the AKI score was similar, it was slightly higher in patients
who developed infection; more patients in this group
showed more severe renal injury, requiring increased use of
dialysis. The greater requirement of vasopressor support
during surgery in this group may also be linked to the
greater requirements in dialysis, thus affecting the clinical
course after LT. Also, these patients had longer hospital
stays but not in the ICU. This condition may reﬂect the
above-mentioned facts, the time of occurrence of infection
after LT (after ICU discharge), and dialysis requirement but
can also be the consequence of more infections detected
and resulting in delayed hospital discharge.
The occurrence of opportunistic infections is in accor-
dance with that described in the literature [21]. Fungal in-
fections appeared earlier, but other opportunistic infections
appeared later [22,23].
Study Limitations
We could not access the donor’s data, apart from the
donation from FAP patients, a factor that did not inﬂuence
the occurrence of infections. These data could be critical to
understand or add new risk factors to those already known.
In future studies, this fact may be a subject for separate
analysis.
A large group of unknown isolates was found. Although
cultures are requested frequently, and most often bacterial
infection is suspected and the infection site is detected, the
speciﬁc agent is not always isolated. Other diagnostic tools
for infections, using molecular diagnosis, could be useful in
these cases.
Most studies distinguish early and late infections after LT.
We decided to provide full data, but also presented the
mean time of occurrence of all infectious sites, so we assume
that it would be easy to identify them. We also describe that
gram-negative bacteria are more common in later in-
fections, thus occurring later after LT.
CONCLUSION
In this retrospective study, we found a 41% prevalence of
infection in a 2-year follow-up. The most frequent were
undetermined infections, and most deaths were due to
sepsis with multiorgan failure. Biliary tract infections were
frequent, with a mean time of occurrence of 160.4  167.7
days after transplant. More prevalent were Gram positivebacteria, although Gram negative bacteria were more
frequently isolated later after LT. The aminotransferase
levels were higher in patients without infection, whereas
dialysis requirement and hospital stay were higher in pa-
tients who presented with infections. Donor variables could
not be assessed and deserve a separate analysis in future
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